We extended our previous genome-wide association study for psoriasis with a multistage replication study including 8,312 individuals with psoriasis (cases) and 12,919 controls from China as well as 3,293 cases and 4,188 controls from Germany and the United States and 254 nuclear families from the United States. We identified six new susceptibility loci associated with psoriasis in the Chinese study containing the candidate genes ERAP1, PTTG1, CSMD1, GJB2, SERPINB8 and ZNF816A (combined P < 5 × 10 −8 ) and replicated one locus, 5q33.1 (TNIP1-ANXA6), previously reported (combined P = 3.8 × 10 −21 ) in the European studies. Two of these loci showed evidence for association in the German study at ZNF816A and GJB2 with P = 3.6 × 10 −3 and P = 7.9 × 10 −3 , respectively. ERAP1 and ZNF816A were associated with type 1 (early onset) psoriasis in the Chinese Han population (test for heterogeneity P = 6.5 × 10 −3 and P = 1.5 × 10 −3 , respectively). Comparisons with the results of previous GWAS of psoriasis highlight the heterogeneity of disease susceptibility between the Chinese and European populations. Our study identifies new genetic susceptibility factors and suggests new biological pathways in psoriasis.
Psoriasis is a chronic inflammatory hyperproliferative skin disease affecting up to 3% of the population worldwide and has considerable ethnic variation. Family based analyses and population-based epidemiological studies have confirmed the genetic basis of psoriasis 1 and have suggested a genetic influence upon its age of onset 2 . In addition to earlier linkage analyses, genome-wide and candidate gene-association studies have implicated many genomic regions in the pathogenesis of psoriasis [3] [4] [5] [6] , not all of which have been confirmed. However, these genetic signals do not fully account for the observed variation in genetic susceptibility to psoriasis, suggesting that additional genetic factors remain to be discovered. Furthermore, differences in the results of similarly powered genome-wide association studies (GWAS) of psoriasis in Chinese 5 and European 4 populations suggest the existence of allelic and/or locus heterogeneity between different populations.
To explore additional susceptibility factors for psoriasis, we performed a multistage association study based on our first-stage GWAS (including our initial GWAS samples reported in ref. 5 and an additional 95 healthy controls; Online Methods) followed by replication in six independent cohorts consisting of a Chinese Han population (replications 1 and 2), a Chinese Uygur population Association analyses identify six new psoriasis susceptibility loci in the Chinese population 1 0 0 6 VOLUME 42 | NUMBER 11 | NOVEMBER 2010 Nature GeNetics l e t t e r s (replication 3), a European population from Germany (replication 4) and a population from the United States (replications 5 and 6). We further genotyped SNPs from previously reported loci in the European population in the samples from replication 2 to investigate the possibility of genetic heterogeneity in disease susceptibility between the different populations. The experimental design is summarized in Figure 1 .
In replication 1, 61 SNPs from 51 regions were selected from the GWAS dataset (Online Methods) and genotyped in an independent sample of 4,610 cases and 5,373 controls from the Chinese Han population (Supplementary Table 1 ). Our combined analysis (GWAS and replication 1) showed that four SNPs met the genome-wide significant threshold (P < 5.0 × 10 −8 ): rs3762999 at 5q33.1 (TNIP1-ANXA6), combined P = 1.1 × 10 −12 , odds ratio (OR) = 1.24; rs999556 at 5q33.1 (TNIP1-ANXA6), combined P = 4.3 × 10 −13 , OR = 1.24; rs2431697 at 5q33.3 (PTTG1), combined P = 1.1 × 10 −8 , OR = 1.20; and rs3751385 at 13q12.11 (GJB2), combined P = 1.7 × 10 −10 , OR = 0.85.
After applying standard quality-control procedures as described elsewhere 5 , 20 SNPs with P < 0.05 from replication 1 were genotyped in another independent cohort of 2,024 cases and 5,495 controls from the Chinese Han population (replication 2; Supplementary Table 1) . In the joint association analysis using samples from the GWAS, replication 1 and replication 2, nine SNPs annotated in seven loci reached genome-wide significance: rs151823 at 5q15 (ERAP1), combined P = 9.3 × 10 −9 ; rs999556 and rs3762999 at 5q33.1 (TNIP1-ANXA6), combined P = 3.8 × 10 −21 and combined P = 4.6 × 10 −18 ; rs2431697 at 5q33.3 (PTTG1), combined P = 1.1 × 10 −8 ; rs10088247 and rs7007032 at 8p23.2 (CSMD1), combined P = 4.5 × 10 −9 and combined P = 3.8 × 10 −8 , respectively; rs3751385 at 13q12.11 (GJB2), combined P = 8.6 × 10 −8 (with a combined P from the GWAS and replication 1 = 1.7 × 10 −10 ); rs514315 at 18q22.1 (SERPINB8), combined P = 5.9 × 10 −9 ; and rs9304742 at 19q13.41 (ZNF816A), combined P = 2.1 × 10 −9 ( Table 1) . All of these nine SNPs showed consistent association evidence independently in each replication panel and in the combined analysis of the Chinese Han population. The association at rs3751385, however, showed substantial heterogeneity (I 2 = 50%) between the GWAS and replication 1 samples and the 2 samples (Supplementary Table 2) . Consequently, the analysis of the combined GWAS, replication 1 and replication 2 samples (under a random effects model) yielded a less significant association (combined P = 8.57 × 10 −8 ) than the analysis of the GWAS and replication 1 samples only (combined P = 1.7 × 10 −10 ). The association at rs3751385 in the combined GWAS and replication 1 samples satisfied the genome-wide criteria for significance, although the association in the combined GWAS, replication 1 and replication 2 samples was barely below the genome-wide significance threshold. In addition, rs2431697 reached genome-wide significance (P = 1.11 × 10 −8 ) in the combined results of the GWAS and replication 1, although its genotyping failed in replication 2. The association results of the other 52 SNPs are summarized in Supplementary Table 3 .
Of these nine SNPs, two (rs999556 and rs3762999) in strong linkage disequilibrium (LD) with each other (r 2 = 0.97) were located in the same region (TNIP1-ANXA6) as rs17728338, which has previously been associated with psoriasis in the European population 4 Chr., chromosome.
a P values from the Cochran-Armitage trend test. b GWAS combined with replication 1 and replication 2. c P values from the joint analysis using either a fixed effect model or random effects model (Online Methods).
l e t t e r s logistic regression analysis showed that the associations of rs999556 and rs3762999 were dependent upon the association at rs17728338 in our GWAS dataset, providing evidence that all three SNPs link to the same disease association in the Chinese Han population. To address this question in the European population, we performed a multivariate logistic regression analysis using two European GWAS samples that are, in part, subsets of replications 4 and 5. The results showed that of these three SNPs, only rs17728338 was strongly associated with psoriasis in the European population (P = 1.7 × 10 −8 ), rs999556 was not associated with psoriasis (P = 0.96), rs3762999 was also not associated with psoriasis (P = 0.062), and the associations with rs999556 and rs3762999 were dependent upon the association with rs17728338. Thus, although LD in this region is apparently more extensive in the Chinese than in the European population, rs17728338 is the best known tag for the TNIP1-ANXA6 susceptibility locus for psoriasis in both populations.
To further assess the impact of the six new loci on genetic risk for psoriasis in diverse populations, we analyzed genotyping data from four additional cohorts: a Chinese Uygur (replication 3, involving 539 cases and 824 controls), a German (replication 4, involving 823 cases and 1,840 controls) and two US populations (replication 5, involving 2,470 cases and 2,348, controls, and replication 6, involving 254 nuclear families described elsewhere [7] [8] [9] ). Notably, the C allele of rs9304742 in the ZNF816A region showed a consistent protective effect among the Chinese Han (P = 2.1 × 10 −9 , OR = 0.88), the Chinese Uygur (P = 1.7 × 10 −3 , OR = 0.77) and the German populations (P = 7.9 × 10 −3 , OR = 0.84); suggestive evidence for a protective effect of the A allele of rs11084211 (which is in strong LD with the C allele of rs9304742) was also seen in the US cohort from replication 5 (P = 1.6 × 10 −2 , OR = 0.90) ( Table 2 ). In addition, rs151823 at 5q15 (ERAP1) showed consistent association (P = 2.9 × 10 −5 , OR = 0.69) in the Chinese Uygur sample, and rs3751385 at 13q12.11 (GJB2) showed consistent association (P = 3.6 × 10 −3 , OR = 0.79) in the German sample. However, in the combined analysis of the German and US case-control samples (Online Methods), none of these newly associated SNPs conferred a significant risk for psoriasis, although it was not possible to test association with ZNF816A ( Table 2) . Indeed, all six loci showed significant heterogeneity between the Chinese samples and the samples of European ancestry (I 2 > 0.40; Supplementary Table 4) .
Because the PTTG1 SNP rs2431697 is located fairly close to IL12B (within ~1.1 Mb), we also carried out a multivariate logistic regression analysis conditioning on the genetic effects of both rs7709212 and rs3213094 within the IL12B locus in our initial GWAS and found that rs2431697 still showed significant association in the Chinese Han population (P = 2.7 × 10 −3 ). This suggests that the effects of both loci are independent. In contrast, no association was seen for PTTG1 in the European studies ( Table 2) , whereas IL12B was seen to be strongly associated 4 .
In an attempt to uncover susceptibility genes underlying each of the association signals, we investigated the patterns of recombination and LD around the associated SNPs and identified the gene(s) located within each region of LD (Supplementary Fig. 1 ). Of these nine SNPs, seven were within six genes or LD blocks at 5q15 (ERAP1), 5q33.3 (PTTG1), 8p23.2 (CSMD1), 13q12.11 (GJB2), 18q22.1 (SERPINB8) and 19q13.41 (ZNF816A), where a single gene was found within the LD block harboring the association. The remaining two SNPs were located at 5q33.1, where two genes (TNIP1 and ANXA6) were identified in the LD region. TNIP1 has previously been considered a susceptibility gene for psoriasis in European populations due to its important role working downstream of TNF-α to negatively regulate NF-κB 4 and the fact that its encoded protein binds to the product of another psoriasis-associated gene (TNFAIP3). However, ANXA6 might also be implicated in the 10 .
To further explore the potential biological implications of the other six newly discovered susceptibility genes (ERAP1, PTTG1, CSMD1, GJB2, SERPINB8 and ZNF816A), we performed a literature search. ERAP1 (encoding endoplasmic reticulum aminopeptidase 1) is an interferon-γ-induced aminopeptidase with several proposed biological functions in the endoplasmic reticulum, including the trimming of peptide antigens to an optimal length for binding to major histocompatibility complex class I molecules 11 . Furthermore, ERAP1 is also associated with ankylosing spondylitis, another major class I-associated autoimmune disease, in both European-ancestry and Chinese populations 12, 13 . Given that HLA-Cw6 is much more strongly associated with type 1 than type 2 (late onset) psoriasis in both the Chinese and European populations 14 , it is of interest that ERAP1 was preferentially associated with type 1 psoriasis in the combined Chinese Han datasets (rs151823, P = 6.5 × 10 −3 , OR = 0.88; Supplementary Table 5) .
PTTG1 (the pituitary tumor transforming gene) encodes a multifunctional protein with roles in the control of mitosis, cell transformation, DNA repair and gene regulation 15 and has in vitro angiogenic activity 16 , at least in part through the regulation of VEGF 17 , which in turn has been reported to be overexpressed psoriasis plaques 18 . Notably, the TNFAIP3, TNIP1 and PTTG1 regions are now genetically implicated in both psoriasis and systemic lupus erythematosus (SLE) 4, 19, 20 .
CSMD1 (encoding CUB and Sushi multiple domains 1) is a tumor suppressor gene expressed in areas of regenerative growth such as skin and epithelial cells 21 . Higher expression levels of CSMD1 correlated with tumor differentiation, suggesting that the gene could contribute to the pathogenesis of psoriasis by influencing keratinocyte differentiation 22 .
Connexins form gap junctions, which play an important role in regulating homeostasis and differentiation in many tissues 23 . Encoded by GJB2 (the gap junction protein beta 2 gene), connexin 26 is highly upregulated in psoriasis lesions 24 , and a transgenic mouse overexpressing GJB2 in suprabasal keratinocytes exhibits several features of psoriasis 25 .
SERPINB8 (the serpin peptidase inhibitor clade B member 8 gene) is a gene encoding one of a family of serine protease inhibitors and is upregulated in psoriasis lesions 26 . It has been suggested that this family of protease inhibitors contributes to the pathophysiology of psoriasis and other common inflammatory skin diseases 27, 28 .
ZNF816A (the zinc finger protein 816A gene) encodes a zinc-finger protein. Zinc finger domains function as specific modules for protein recognition and have multiple regulatory functions, such as the recognition of RNA and proteins 29 . Furthermore, ZNF816A belongs to the same functional class of proteins as ZNF313 (the zinc finger protein 313 gene), which was recently identified as a new psoriasis susceptibility gene 30 . Like ZNF313, ZNF816A appears to be associated with type 1 (early onset) psoriasis in the combined Chinese Han datasets (rs9304742, P = 1.5 × 10 −3 , OR = 0.85; Supplementary Table 5) .
Along with our genome-wide study, we further investigated 15 SNPs from 8 loci in replication 2 that were previously reported to be associated with psoriasis in European populations 4 (Online Methods). In addition to the TNIP1 SNP rs17728338, which was highly associated with psoriasis in the combined Chinese Han data (GWAS and replication 2, 3,163 cases and 6,722 controls), only three genes, IL23R, IL13 and TNFAIP3, showed suggestive evidence for association (combined P = 4. Table 6 ). In most cases, the minor alleles and their allele frequencies (Supplementary Table 6 ) were similar between the European and Chinese Han populations, suggesting genetic heterogeneity of psoriasis within the two ethnic groups. However, it is possible that the power of the sample was not sufficient to detect risk SNPs with a low minor allele frequency in the Chinese Han population, as is likely to be the case for rs2066808 and rs12983316 (minor allele frequency < 0.05; Supplementary Table 6) . It is also possible that differences in patterns of linkage disequilibrium account for the ethnic diversity of psoriasis, as some of the associated variants identified in the European population were not sufficiently tagged by any SNP screened in our GWAS.
This study was designed to maximize statistical power in a costeffective manner by adopting a multistage analysis strategy in several large Chinese and European population samples, resulting in the identification of six new susceptibility loci. Our findings increase the number of genetic risk factors for psoriasis, some of which have also been implicated in other autoimmune diseases. Our results also highlight new and plausible biological pathways in psoriasis, suggest additional genetic factors that may contribute to its age of onset and provide insight into the genetic heterogeneity of psoriasis across different ethnic populations. Further studies using large samples drawn from diverse ethnic populations will be required to provide a more comprehensive understanding of the global genetics of psoriasis. URLs. R, http://www.r-project.org/.
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Subjects.
To maximize the power of the study, we included data from our previously published GWAS of psoriasis, as well as data from 95 newly genotyped controls (in total, 1,139 psoriasis cases and 1,227 healthy controls). Replication 1 (4,610 cases and 5,373 controls) and replication 2 (2,024 cases and 5,495 controls) samples were recruited from the Chinese Han population through collaboration with multiple hospitals in China. The replication 3 Chinese Uygur population consisted of 539 cases and 824 matched controls, obtained from Xinjiang Uygur Autonomous Region in China. The clinical diagnosis of all subjects for GWAS and replications 1-3 were confirmed by at least two dermatologists. We collected clinical information from the subjects through a full clinical checkup, and additional demographic information from both the cases and controls were obtained through a structured questionnaire as used previously 5, 19 . All controls were clinically assessed as being without psoriasis, other autoimmune disorders, systemic disorders and family history of autoimmune disorders (including first-, second-and third-degree relatives). Informed consent was obtained from all the participants. The study was approved by each institutional ethical committee and conducted according to Declaration of Helsinki principles. Replication 4 (823 cases and 1,840 controls) from Germany was provided by A. Franke. Replication 5 (2,470 cases and 2,348 controls) from the United States was provided by J.T. Elder and replication 6 (254 nuclear families with two siblings with psoriasis) from the United States was provided by A. Bowcock [7] [8] [9] . All the controls and cases for each replication cohort were sampled from the same locality and the same population to assure minimal population stratification effects for each replication.
SNP selection for replication. We adopted two approaches to select SNPs for our replication 1 study. As a first approach, we reanalyzed our initial GWAS data after the addition of 95 newly genotyped controls (1,139 cases and 1,227 healthy controls). We excluded all SNPs with minor allele frequency <0.05 both in cases and controls, with Hardy-Weinberg equilibrium test P values <0.01 in controls, or that were genotyped for replication in our previous study. We then selected the 21 top SNPs with an association of P < 10 −5 . As a second approach, we increased our power to identify promising SNPs for further replication by incorporating 3,946 cases with other immune-related diseases (SLE 19 , leprosy 31 , vitiligo and atoptic dermatitis) as 'pseudo-controls' . When combined with the initial GWAS data used in the first approach, this yielded 1,139 cases and 5,173 controls, from which we selected the 40 top SNPs with an association P < 10 −5 . We note that all 6,312 samples are from the Chinese Han population and were genotyped using the same Illumina Human 610-Quad BeadChips. This same strategy for improving the power of a GWAS analysis was also used in our previously published study on SLE 19 , and a similar strategy has been employed by other groups, such as deCODE 32 and the Wellcome Trust Case Control Consortium 33 . We emphasize that these 3,946 'pseudo-controls' were only used in the process of SNP selection and were not included in the replication study or in the final joint association analysis of the combined samples. In total, these two approaches provided 61 SNPs for replication 1.
In replication 2, 35 SNPs were genotyped. These included 20 SNPs with P < 0.05 in replication 1 and 15 SNPs from 8 loci previously found to be associated with psoriasis in the European population (2 SNPs from each locus, one with the same SNP identification as previously reported in European population and one with the highest P value in our initial GWAS excluding the confirmed TNIP1 region) to investigate the heterogeneity of disease susceptibility between the Chinese and European populations.
Genotyping and quality control in GWAS. Our GWAS dataset was comprised of 620,901 SNPs and CNV probes genotyped in 1,139 psoriasis cases and 1,132 controls; we added additional genotype data from 95 healthy controls (Table 1) in the current study. A Cochran-Armitage trend test was conducted to calculate the genotype-phenotype association as described previously 5 . A quantile-quantile plot showed an excess of significant associations after removal of major histocompatibility complex SNPs. Population structure analysis indicated a minimal overall inflation of the genome-wide statistical results due to population stratification (λ GC = 1.078) (Supplementary Fig. 2a-c) .
Genotyping and quality control in the replication study. Genotyping analyses in replications 1-3 (including replication for the Chinese Uygur population) were conducted by using the Sequenom MassArray system and Biosystems TaqMan assays at the State Key Laboratory Incubationg Base of Dermatology, Ministry of National Science and Technology, Hefei, Anhui, China. Approximately 15 ng of genomic DNA was used to genotype each sample. Locus-specific PCR and detection primers were designed using the MassARRAY Assay Design 3.0 software (Sequenom) following the manufacturer's instructions. The DNAs were amplified by multiplex PCR reactions, and the PCR products were then used for locus-specific single-base extension reactions. The resulting products were desalted and transferred to a 384-element SpectroCHIP array. Allele detection was performed using MALDI-TOF mass spectroscopy. The mass spectrograms were analyzed by the MassARRAY TYPER software (Sequenom). Genotyping of replications 4 and 5 was done using TaqMan assays (Applied Biosystems) at the Christian-Albrechts University Kiel in Kiel, Germany and the University of Michigan in Michigan, USA. Quality control was performed in each dataset separately using PLINK version 1.05 (ref. 34 ). In each case-control cohort (replications 1-5), we excluded SNPs with a call rate <95%, low minor allele frequency (<0.05) or deviation from HardyWeinberg equilibrium proportions (P < 0.01) in the controls. Genotyping of replication 6 conducted at Washington University School of Medicine in St. Louis, Missouri, USA was performed with the Sequenom MassArray system. Primer sequences are available upon request. Quality control of replication 6 has been described elsewhere 6 . The cluster plots from the Illumina, Sequenom and TaqMan analyses were checked to confirm their good quality.
Statistical analysis. Ninety-five additional healthy controls were incorporated into a reanalysis of the GWAS dataset as described previously 5 . The quantilequantile plot and genomic control were calculated using the statistical analysis program R (see URLs), which evaluated the overall significance of the genomewide association results and the potential impact of population stratification. All the statistical results were reported without genomic control correction as the minimal impact of population stratification to be found. The remaining samples were subsequently assessed for population outliers and stratification using a principal component analysis-based approach 5, 35 . First, all samples were analyzed together with the 206 reference samples from the International HapMap Project: 57 Yoruba samples from Ibadan, Nigeria (YRI); 44 Japanese samples from Tokyo, Japan (JPT); 45 Han Chinese samples from Beijing, China (CHB); and 60 CEPH (Utah residents with ancestry from northern and western Europe) samples (CEU). No population outliers were detected. Afterward, we carried out prinicipal components analysis for all the remaining case and control samples. After quality control, we analyzed genotype data for 494,902 SNPs in 1,139 cases and 1,227 controls in the GWAS stage.
We conducted a Cochran-Armitage trend test in five replication samples (replications 1-5, respectively). Heterogeneity tests (I 2 and P values of the Q statistics) between different groups was performed using the method described previously 36 . The extent of heterogeneity was assessed by using the I 2 index 37 . In general, an I 2 of less than 30% was considered as no heterogeneity, an I 2 value of 30% to 50% was considered as moderate heterogeneity and an I 2 value above 50% was considered as strong heterogeneity. Therefore, we set the threshold of I 2 to be 30% in our analysis. If I 2 was less than 30%, the fixed effect model (Mantel-Haenszel) was used to combine the results of different cohorts 38 ; otherwise, the random effect model (DerSimonian-Laird) was used 39 . The combined analyses were separately performed in the Chinese Han (GWAS and replication 1, replication 1 and replication 2 or GWAS and replication 1 and replication 2) and European populations (replication 4 and replication 5). Because nuclear families with affected sibling pairs (replication 6) were genotyped, we estimated the kinship coefficient by the program KinInbcoef 40 , and then we performed a case-control association test by a quasi-likelihood score test as previously described 41 . We estimated the allele frequency from a linear unbiased model, and the odds ratios were obtained by the formula
where g is the estimated allele frequency in cases and f is the estimated allele frequency in controls. All P values from the replication analysis were reported without correction for multiple testing. Multiple logistic regression analyses were used to test association patterns within 5q33.3 (PTTG1 and IL12B) and within 5q33.1 (TNIP1-ANXA6). Recombination plots of discovered susceptibility loci were generated using the information from the HapMap project.
